The Abramson Cancer Center of the University of Pennsylvania has found its new leader in-house.
Dr. Robert Vonderheide, a professor in cancer research at Penn’s Perelman School of Medicine and a noted expert in immunotherapy, was promoted to the director post after serving as the cancer center’s associate director for translational research and executive director of its translational centers of excellence program for more than a decade.
He will begin his new role as director on July 1. He succeeds Dr. Chi Van Dang, who was director of Abramson Cancer Center since 2011. In December he accepted a new job as scientific director of the Ludwig Institute for Cancer research in New York City.
“Dr. Vonderheide’s career at Penn has been marked by continuous innovation in areas that were scarcely a possibility in the field when he arrived here in 2001,” said Dr. J. Larry Jameson, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System.
To read the full story, click here.
For more business news, visit Philadelphia Business Journal.
